Metabolism - Clinical and Experimental
Volume 58, Issue 9 , Pages 1297-1305, September 2009

A herbal extract with acetyl–coenzyme A carboxylase inhibitory activity and its potential for treating metabolic syndrome

  • Chi-Hua Chen

      Affiliations

    • Food Industry Research Development Institute, Hsinchu 300, Taiwan
    • These authors contributed equally to this work.
  • ,
  • Mei-Yui Chang

      Affiliations

    • Institute of Nutrition, China Medical University, Taichung 404, Taiwan
    • These authors contributed equally to this work.
  • ,
  • Yu-Shen Lin

      Affiliations

    • Institute of Nutrition, China Medical University, Taichung 404, Taiwan
  • ,
  • Da-Gin Lin

      Affiliations

    • Department of Biotechnology, Transworld Institute of Technology, Yunlin 640, Taiwan
  • ,
  • Shiow-Wen Chen

      Affiliations

    • Food Industry Research Development Institute, Hsinchu 300, Taiwan
  • ,
  • Pei-Min Chao

      Affiliations

    • Institute of Nutrition, China Medical University, Taichung 404, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 4 22053366; fax: +886 4 22062891.

Received 28 January 2009; accepted 20 April 2009. published online 08 June 2009.

Abstract 

Acetyl–coenzyme A carboxylase (ACC) plays a crucial role in fatty acid metabolism, and its inhibition is an effective approach for treating metabolic syndrome. Partially purified ACC from rat liver was used to screen herbs commonly used in Taiwanese folk medicine for ACC inhibitory effects. An ethanol extract of Polygonum hypoleucum Ohwi (EP), the Taiwan tuber fleece flower, was found to have the highest inhibitory activity (half-maximal inhibitory concentration = 30 μg/mL). We then tested the physiologic effects of EP using high-fat (HF) diet–fed C57BL/6J mice. After 4 weeks, body weight and levels of blood glucose, insulin, triacylglycerol, total cholesterol, and leptin were significantly reduced (P < .05) in mice fed a 3% EP-containing HF diet. The EP also improved the glucose tolerance and insulin sensitivity of HF diet–fed mice. In addition, EP at concentrations of 0.0725 and 0.145 mg/mL (2.5- and 5-fold higher than the half-maximal inhibitory concentration) was also effective in decreasing ACC and fatty acid synthase activity and the triacylglycerol content of HepG2 cells incubated in high-glucose (30 mmol/L) medium. These results show that EP, acting by inhibiting ACC activity, is effective in alleviating the symptoms associated with metabolic disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(09)00148-6

doi:10.1016/j.metabol.2009.04.012

Metabolism - Clinical and Experimental
Volume 58, Issue 9 , Pages 1297-1305, September 2009